Hajdúch Marián M.D., Ph.D.

User picture
Academic title: Associate Professor
Phone: +420 585632082, +420 585632083
Groups: IMTM, LEM, STAFF, SUPERVISOR

About me

Scientist and medical professional mainly involved in molecular and translational medicine (disease area oncology. rare and infectious diseases); long-term experience in project management; R&D and technology transfer activities, including the construction and management of large research infrastructures. Founding director of the Institute of Molecular and Translational Medicine, Palacky University in Olomouc, CZ. He has been involved as principal investigator, investigator or clinical site manager in 19 clinical trials; actively participated in the research and/or management of >50 national and international projects; established Cancer Research Czech Republic as a major charity to support cancer research in CZ; spin-off companies focused on manufacturing of molecular diagnostics, bioinformatics and drug development; leader/co-leader drug development initiatives with one registered drug on market, several products in clinical trials, >35 in vitro diagnostic products on market, several CE IVD certified. Former Chair of the Boards of National Director and current Czech National Director for European Translational Medicine Infrastructure (EATRIS-ERIC); participated in creation of national network for personalized medicine and cancer management policies. Published more than >350 papers, 21 books/chapters, >40 patents, >6700 SCI citations, H-index 41.

Journals

SUAREZ, A., K. CHAVEZ, P. MARTINEZ, J. BUBIS, Z. BLANCO, H. RAMIREZ, J. GARMENDIA, J. DE SANCTIS, S. GURSKÁ, P. DŽUBÁK, M. HAJDÚCH, J. CHARRIS
New 1,2,3-Triazole Hybrids as Anticancer Agents: Design, Synthesis, Characterization, and In Silico Studies. ChemMedChem. 2026, 21(15), e70425, ISSN: 1860-7179 , PMID: 42552512,  PDF.
HEBENBROCK, M., S. GURSKÁ, K. BOGDANOVÁ, K. RESOVA, M. KOLÁŘ, F. BOISTEN, M. HAJDÚCH, P. DŽUBÁK, J. MULLER
Cytotoxicity and antimicrobial activity of platinum(II) complexes based on the ligand precursor 2-phenyl-6-(1,2,3-triazol-4-yl)pyridine - influence of substituent and ancillary ligand on selectivity and activity. Zeitschrift für Naturforschung. C, Journal of biosciences. 2026, ISSN: 0939-5075, PMID: 42214343,  PDF.
BACHOŘÍK, J., I. FRYDRYCH, S. GURSKÁ, S. DOSTAL, J. POKORNÝ, M. HAJDÚCH, M. URBAN
New Synthetic Approach to C‑30 Ethers, Esters, and Amines of Betulin Using the Mitsunobu Reaction and Biological Evaluation of the Products. ACS Omega. 2026, 11(16), 24564-24579, ISSN: 2470-1343, PMID: 42077890,  PDF.

Books & book chapters

HAJDÚCH, M., J. DRÁBEK, R. TROJANEC
Biologická léčiva: Teoretické základy a klinická praxe, 1. vyd, Praha, Grada Publishing, 2012, 219 s, Dedication: BIOMEDREG CZ.1.05/2.1.00/01.0030, ISBN: 978-80-247-3727-0,
DRÁBEK, J., J. BERKOVCOVÁ, P. DŽUBÁK, M. HAJDÚCH, M. KHOYLOU, V. KOUDELÁKOVÁ, J. SROVNAL, M. STAŇKOVÁ, R. TROJANEC
Detekce nádorových biomarkerů v molekulárně biologické laboratoři, 1. vyd, Olomouc, Univerzita Palackého v Olomouci, 2012, 144 s, Dedication: MOLONKOL CZ.1.07/2.3.00/09.0089, ISBN: 978-80-244-3002-7,
HAJDÚCH, M., J. DRÁBEK, R. TROJANEC
Význam biomarkerů pro indikaci cílené biologické léčby v onkologii, 1. vyd, Praha, Grada Publishing, 2012, 2.8, 137-149, Dedication: BIOMEDREG CZ.1.05/2.1.00/01.0030, ISBN: 978-80-247-3727-0,

Intellectual property

METHOD OF IDENTIFICATION OF ENTITIES FROM MASS SPECTRA - EP 18184710.4 (Hruška)
  1. Published Application PCT/EP2019/069552 under WO 2020/016428 (23.1.2020)
  2. Published Application EP 19746050.4 under EP3824292 (26.5.2021)
  3. Patent: CA 3.106.053. Granted: 11.6.2024. Ownership: Palacký University Olomouc. Inventors: HRUŠKA Miroslav, HAJDÚCH Marián, DŽUBÁK Petr
  4. Patent: JP 7218019. Granted: 27.1.2023. Ownership: Palacký University Olomouc. Inventors: HRUŠKA Miroslav, HAJDÚCH Marián, DŽUBÁK Petr

Status: Available

PYRIDINOPYRROLOPYRIMIDINE RIBONUCLEOSIDES FOR THERAPEUTIC USE - PV 2018-121 (Veselovská)
  1. Patent: CZ 308104. Granted: 27. 11. 2019. Ownership: Institute of Organic Chemistry and Biochemistry CAS, Palacký University Olomouc. Inventors: VESELOVSKÁ Lucia, HOCEK Michal, HAJDÚCH Marián, DŽUBÁK Petr
  2. Published Application PCT/CZ2019/050008 under WO 2019/174657 (19.9.2019)
  3. Patent: EP 3765475. Granted: 15.9.2021. Ownership: Institute of Organic Chemistry and Biochemistry CAS, Palacký University Olomouc. Inventors: VESELOVSKÁ Lucia, HOCEK Michal, HAJDÚCH Marián, DŽUBÁK Petr
  4. Patent: US 11,299,510. Granted: 12.4.2022. Ownership: Institute of Organic Chemistry and Biochemistry CAS, Palacký University Olomouc. Inventors: VESELOVSKÁ Lucia, HOCEK Michal, HAJDÚCH Marián, DŽUBÁK Petr
  5. Patent: JP 6973761. Granted: 8.11.202. Ownership: Institute of Organic Chemistry and Biochemistry CAS, Palacký University Olomouc. Inventors: VESELOVSKÁ Lucia, HOCEK Michal, HAJDÚCH Marián, DŽUBÁK Petr

Status: Available

BIOAVAILABLE DITHIOCARBAMATE-METAL COMPLEX NANOPARTICLES, METHOD OF PREPARATION AND USE THEREOF - EP 17193240.3 (Škrott) DISULFIRAM I
  1. Patent: EP 3459526. Granted: 24.2.2021. Ownership: Palacký University Olomouc. Inventors: Škrott Zdeněk, Mistrík Martin, Hajdúch Marián, Bártek Jiří, Džubák Petr, Zbořil Radek.
  2. Published Application: PCT/EP2018/076098 under WO 2019/063601 (4.4.2019)
  3. Patent: US 11,766,404. Granted: 26.9.2023. Ownership: Palacký University Olomouc. Inventors: Škrott Zdeněk, Mistrík Martin, Hajdúch Marián, Bártek Jiří, Džubák Petr, Zbořil Radek.
  4. Patent: AU 2018340510. Granted: 5.8.2021. Ownership: Palacký University Olomouc. Inventors: Škrott Zdeněk, Mistrík Martin, Hajdúch Marián, Bártek Jiří, Džubák Petr, Zbořil Radek.
  5. Patent: IL 273652. Granted: 2.1.2024. Ownership: Palacký University Olomouc. Inventors: Škrott Zdeněk, Mistrík Martin, Hajdúch Marián, Bártek Jiří, Džubák Petr, Zbořil Radek.
  6. Patent: CA 3,076,855. Granted: 26.4.2022. Ownership: Palacký University Olomouc. Inventors: Škrott Zdeněk, Mistrík Martin, Hajdúch Marián, Bártek Jiří, Džubák Petr, Zbořil Radek.
  7. Patent: KR 10-2456683. Granted: 14.10.2022. Ownership: Palacký University Olomouc. Inventors: Škrott Zdeněk, Mistrík Martin, Hajdúch Marián, Bártek Jiří, Džubák Petr, Zbořil Radek.
  8. Patent: JP 7149624. Granted: 29.9.2022. Ownership: Palacký University Olomouc. Inventors: Škrott Zdeněk, Mistrík Martin, Hajdúch Marián, Bártek Jiří, Džubák Petr, Zbořil Radek.
  9. Patent: MX 396,552. Granted: 17.10.2022. Ownership: Palacký University Olomouc. Inventors: Škrott Zdeněk, Mistrík Martin, Hajdúch Marián, Bártek Jiří, Džubák Petr, Zbořil Radek.
  10. Patent:  BR 112020005823-8. Granted: 12.11.2024. Ownership: Palacký University Olomouc. Inventors: Škrott Zdeněk, Mistrík Martin, Hajdúch Marián, Bártek Jiří, Džubák Petr, Zbořil Radek.

Status: Available

Doctoral mentorship

Vojta Petr Ph.D.

Study of genome and transcriptome variability employing data processing from massive parallel DNA sequencing

Status: Graduated from 2009 to 2018.

Kudlová Natálie M.Sc.

High throughput sequencing methods in biomarker identification and validation

Status: Graduated from 2014 to 2022.

Trojanec Radek Ph.D., MBA

Cytogenetic changes in patients with solid tumors

Status: Graduated.

Open positions

1 Molecular and cellular biology
Project: Identification of molecular targets and mechanisms of drug resistance by cellular methods biology and proteomics
Supervisors: Džubák Petr M.D., Ph.D., Hajdúch Marián M.D., Ph.D.
Available: 2
Intended for: Doctoral training
Summary: 2 places in full-time study
1 Medical chemistry and clinical biochemistry
Project: Research and development of small-molecule drugs
Supervisors: Hajdúch Marián M.D., Ph.D.
Available: 2
Intended for: Doctoral training
Summary: 2 full-time positions
2 Biomarkers: Identification and validation
Project: Identification of proteomic biomarkers in exhaled air condensate in patients with systemic or pulmonary disease
Supervisors: Džubák Petr M.D., Ph.D., Hajdúch Marián M.D., Ph.D.
Available: 2
Intended for: Doctoral training
Summary: 2 places in full-time study
Project: Genetic and epigenetic biomarkers of cancer diseases
Supervisors: Slavkovský Rastislav Ph.D., Džubák Petr M.D., Ph.D., Hajdúch Marián M.D., Ph.D., Drábek Jiří Ph.D.
Available: 3
Intended for: Doctoral training
Summary: 3 places in full-time or combined form of study
3 Chemical biology and experimental therapeutics
Project: Study of basic pharmacokinetic properties (ADME) of new drugs in preclinical development
Supervisors: Lišková Barbora Ph.D., Hajdúch Marián M.D., Ph.D.
Available: 1
Intended for: Doctoral training
Summary: 1 place in full-time study
Project: Drug repurposing for the treatment and prevention of diseases
Supervisors: Hajdúch Marián M.D., Ph.D., Dömling Alexander PhD.
Available: 1
Intended for: Doctoral training
Summary: 1 place in full-time study
Project: Antitumor drugs targeting nucleic acid metabolism
Supervisors: Hajdúch Marián M.D., Ph.D., Džubák Petr M.D., Ph.D.
Available: 2
Intended for: Doctoral training
Summary: 2 places in full-time study
1 Bioinformatics / Chemoinformatics
Project: Bioinformatics processing of big data within clinical and preclinical studies
Supervisors: Hajdúch Marián M.D., Ph.D., Pavliš Petr Ph.D.
Available: 3
Intended for: Doctoral training
Summary: 3 places in full-time or combined form of study
16 Molecular and Translational Medicine
Project: Identification of molecular targets and mechanisms of resistance in anticancer drugs using cell biology and proteomics
Supervisors: Hajdúch Marián M.D., Ph.D.
Available: 1
Intended for: Doctoral training
Summary: 1 full-time position
Project: Anticancer drugs targeting nucleic acid metabolism
Supervisors: Hajdúch Marián M.D., Ph.D.
Available: 1
Intended for: Doctoral training
Summary: 1 full-time position
Project: Bioinformatics processing of large datasets in clinical and preclinical studies
Supervisors: Hajdúch Marián M.D., Ph.D., Pavliš Petr Ph.D.
Available: 2
Intended for: Doctoral training
Summary: 2 positions (full-time or part-time)
Project: Anticancer drugs targeting nucleic acid metabolism
Supervisors: Hajdúch Marián M.D., Ph.D., Džubák Petr M.D., Ph.D.
Available: 2
Intended for: Doctoral training
Project: Identification of molecular targets and mechanisms of resistance in antitumor drugs
Supervisors: Srovnal Josef M.D., Ph.D., Hajdúch Marián M.D., Ph.D.
Available: 2
Intended for: Doctoral training
Summary: 2 places in full-time study
Project: Physiology and pathophysiology of aging
Supervisors: Hajdúch Marián M.D., Ph.D., Voller Jiří Ph.D.
Available: 2
Intended for: Doctoral training
Summary: 2 places in full-time study
Project: Development of drugs in the field of small molecules 2 places in full-time study
Supervisors: Dömling Alexander PhD., Hajdúch Marián M.D., Ph.D.
Available: 2
Intended for: Doctoral training
Summary: 2 places in full-time study
Project: Diagnosis and treatment of rare diseases
Supervisors: Hajdúch Marián M.D., Ph.D., Srovnal Josef M.D., Ph.D.
Available: 2
Intended for: Doctoral training
Summary: 2 places in full-time study
Project: Diagnosis and treatment of rare diseases
Supervisors: Hajdúch Marián M.D., Ph.D., Srovnal Josef M.D., Ph.D., Adam Tomáš Ph.D.
Available: 3
Intended for: Doctoral training
Summary: 3 full-time positions
Project: Genetic and epigenetic biomarkers in health and disease
Supervisors: Slavkovský Rastislav Ph.D., Džubák Petr M.D., Ph.D., Hajdúch Marián M.D., Ph.D., Drábek Jiří Ph.D., Koudeláková Vladimíra Ph.D.
Available: 5
Intended for: Doctoral training
Project: Identification of proteomic biomarkers in exhaled breath condensate patients with systemic or pulmonary disease
Supervisors: Džubák Petr M.D., Ph.D., Hajdúch Marián M.D., Ph.D.
Available: 2
Intended for: Doctoral training
Project: Biologically active molecules and their therapeutic combinations
Supervisors: Hajdúch Marián M.D., Ph.D.
Available: 2
Intended for: Doctoral training
Project: Identification of proteomic biomarkers in proximal fluids and tissues
Supervisors: Džubák Petr M.D., Ph.D., Hajdúch Marián M.D., Ph.D.
Available: 2
Intended for: Doctoral training
Project: Research and development of agents for cancer, neurodegenerative and infectious diseases
Supervisors: De Sanctis Juan Bautista Ph.D., Hajdúch Marián M.D., Ph.D., Džubák Petr M.D., Ph.D., Urban Milan Ph.D., Das Viswanath M.Sc., Ph.D.
Available: 5
Intended for: Doctoral training
Project: Identification of new derivatives targeting precancerous and tumor lesions and their mechanisms of action
Supervisors: Hajdúch Marián M.D., Ph.D., Džubák Petr M.D., Ph.D.
Available: 2
Intended for: Doctoral training
Summary: 2 full-time positions
Project: New diagnostic, prognostic, and predictive factors in solid tumors
Supervisors: Hajdúch Marián M.D., Ph.D.
Available: 2
Intended for: Doctoral training
Summary: 2 positions (full-time or part-time)

WHERE TO FIND US

Hněvotínská 1333/5
779 00 Olomouc
Czech Republic

+420 585632111
+420 585632180
recepce.umtm@upol.cz
info@imtm.cz

GPS: 49° 35´ 10.1869512" N, 17° 14´ 6.292305" E

ABOUT IMTM

Our mission is to perform basic and translational biomedical research with an aim to better understand the underlying cause of human infectious diseases and cancer, and to develop future human medicines, medical devices and diagnostics. Our vision is to facilitate private-public partnership and research collaboration, and to integrate member researchers into international platforms. LEARN MORE ABOUT IMTM

HELPDESK PORTAL
© 2026 Institute of Molecular and Translational Medicine

This website uses cookies

We use necessary cookies to make the website work. With your consent we also use analytics cookies and show embedded content from other services that may set their own cookies. You can change your choice at any time under "Cookie settings" at the bottom of every page. Privacy policy

Cookie settings

Choose which cookies we may use. Your choice is stored for 6 months. Privacy policy

  • Required for the website to work – e.g. your session when logged in, security and remembering this choice. They cannot be switched off.

  • Help us understand how visitors use the website so we can improve it (Google Analytics, anonymised IP address).

  • Show content embedded from YouTube, X (Twitter), Facebook, Google Maps and Czech Radio. These services may set their own cookies.